Bcr-Abl Directly Activates Stat5 Independent of Jak2

被引:0
|
作者
Hantschel, Oliver D. [1 ]
Eckelhart, Eva [2 ]
Kaupe, Ines [1 ]
Grebien, Florian [1 ]
Wagner, Kay-Uwe [3 ]
Sexl, Veronika [4 ,5 ]
Superti-Furga, Giulio [1 ]
机构
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria
[2] Med Univ Vienna, Ctr Pharmacol & Physiol, Vienna, Austria
[3] Univ Nebraska Med Ctr, Eppley Inst Res Caner & Allied Dis, Omaha, NE USA
[4] Med Univ Vienna, Dept Biomed Sci, Vienna, Austria
[5] Vet Univ Vienna, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:226 / 226
页数:1
相关论文
共 50 条
  • [1] BCR-ABL activates STAT3 via Jak2 and MEK pathways.
    Coppo, P
    Wittner, M
    De Mas, V
    Guillier, M
    Bonnet, ML
    Lacout, C
    Vainchenker, W
    Turhan, AG
    BLOOD, 2003, 102 (11) : 588A - 588A
  • [2] Evidence that Bcr-Abl activates Jak2 by direct tyrosine phosphorylation, and Jak2 activation by Bcr-Abl is involved in blocking apoptosis.
    Xie, SH
    Liu, JX
    Sun, T
    Arlinghaus, RB
    BLOOD, 2000, 96 (11) : 92A - 92A
  • [3] Function of STAT5 Isoforms in Bcr-Abl Positive Cells
    Schaller-Schoenitz, Michael
    Dallmann, Iris
    Ganser, Arnold
    Scherr, Michaela
    Eder, Matthias
    BLOOD, 2011, 118 (21) : 580 - 581
  • [4] Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation
    Xie, SH
    Wang, Y
    Liu, JX
    Sun, T
    Wilson, MB
    Smithgall, TE
    Arlinghaus, RB
    ONCOGENE, 2001, 20 (43) : 6188 - 6195
  • [5] Targeting BCR-ABL and JAK2 in Ph+ ALL
    Hantschel, Oliver
    BLOOD, 2015, 125 (09) : 1362 - 1363
  • [6] In vitro interaction between STAT5 and JAK2;: dependence upon phosphorylation status of STAT5 and JAK2
    Flores-Morales, A
    Pircher, TJ
    Silvennoinen, O
    Gustafsson, JÅ
    Sanchez-Gomez, M
    Norstedt, G
    Haldosén, LA
    Wood, TJJ
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 138 (1-2) : 1 - 10
  • [7] Off-Target Effects of BCR-ABL and JAK2 Inhibitors
    Green, Myke R.
    Newton, Michael D.
    Fancher, Karen M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 76 - 84
  • [8] Jak2 is involved in c-Myc induction by Bcr-Abl
    Shanhai Xie
    Hui Lin
    Tong Sun
    Ralph B Arlinghaus
    Oncogene, 2002, 21 : 7137 - 7146
  • [9] Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
    Shuai, K
    Halpern, J
    tenHoeve, J
    Rao, XP
    Sawyers, CL
    ONCOGENE, 1996, 13 (02) : 247 - 254
  • [10] Jak2 is involved in c-Myc induction by Bcr-Abl
    Xie, SH
    Lin, H
    Sun, T
    Arlinghaus, RB
    ONCOGENE, 2002, 21 (47) : 7137 - 7146